CB
Cadence Bank’s Biogen BIIB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-2,281
| Closed | -$349K | – | 323 |
|
|
2024
Q4 | $349K | Sell |
2,281
-70
| -3% | -$10.7K | 0.02% | 260 |
|
|
2024
Q3 | $456K | Sell |
2,351
-61
| -3% | -$11.8K | 0.03% | 227 |
|
|
2024
Q2 | $559K | Sell |
2,412
-19
| -0.8% | -$4.41K | 0.04% | 180 |
|
|
2024
Q1 | $524K | Buy |
2,431
+14
| +0.6% | +$3.02K | 0.04% | 216 |
|
|
2023
Q4 | $625K | Hold |
2,417
| – | – | 0.05% | 202 |
|
|
2023
Q3 | $621K | Hold |
2,417
| – | – | 0.05% | 196 |
|
|
2023
Q2 | $688K | Buy |
2,417
+35
| +1% | +$9.97K | 0.06% | 187 |
|
|
2023
Q1 | $662K | Sell |
2,382
-27
| -1% | -$7.51K | 0.06% | 192 |
|
|
2022
Q4 | $667K | Sell |
2,409
-32
| -1% | -$8.86K | 0.06% | 192 |
|
|
2022
Q3 | $652K | Buy |
2,441
+107
| +5% | +$28.6K | 0.07% | 178 |
|
|
2022
Q2 | $476K | Sell |
2,334
-77
| -3% | -$15.7K | 0.07% | 136 |
|
|
2022
Q1 | $507K | Sell |
2,411
-88
| -4% | -$18.5K | 0.06% | 135 |
|
|
2021
Q4 | $600K | Buy |
2,499
+6
| +0.2% | +$1.44K | 0.07% | 130 |
|
|
2021
Q3 | $705K | Buy |
2,493
+179
| +8% | +$50.6K | 0.1% | 115 |
|
|
2021
Q2 | $802K | Buy |
2,314
+47
| +2% | +$16.3K | 0.12% | 105 |
|
|
2021
Q1 | $634K | Buy |
2,267
+46
| +2% | +$12.9K | 0.1% | 123 |
|
|
2020
Q4 | $543K | Sell |
2,221
-179
| -7% | -$43.8K | 0.09% | 140 |
|
|
2020
Q3 | $681K | Sell |
2,400
-139
| -5% | -$39.4K | 0.13% | 104 |
|
|
2020
Q2 | $680K | Sell |
2,539
-13
| -0.5% | -$3.48K | 0.14% | 106 |
|
|
2020
Q1 | $808K | Buy |
2,552
+74
| +3% | +$23.4K | 0.2% | 87 |
|
|
2019
Q4 | $735K | Buy |
2,478
+3
| +0.1% | +$890 | 0.14% | 106 |
|
|
2019
Q3 | $577K | Sell |
2,475
-13
| -0.5% | -$3.03K | 0.05% | 129 |
|
|
2019
Q2 | $582K | Buy |
2,488
+51
| +2% | +$11.9K | 0.06% | 126 |
|
|
2019
Q1 | $576K | Buy |
2,437
+87
| +4% | +$20.6K | 0.06% | 128 |
|
|
2018
Q4 | $707K | Buy |
2,350
+55
| +2% | +$16.5K | 0.08% | 105 |
|
|
2018
Q3 | $811K | Sell |
2,295
-77
| -3% | -$27.2K | 0.08% | 107 |
|
|
2018
Q2 | $688K | Buy |
2,372
+200
| +9% | +$58K | 0.06% | 121 |
|
|
2018
Q1 | $595K | Buy |
2,172
+185
| +9% | +$50.7K | 0.06% | 131 |
|
|
2017
Q4 | $633K | Buy |
+1,987
| New | +$633K | 0.06% | 129 |
|